Showing results (1581-1590 of 1,686) with videos related to

Sort By:
Pageof 169
JACC. Cardiovascular Interventions|January 20, 2018
Early Outcomes With the Evolut PRO Repositionable Self-Expanding Transcatheter Aortic Valve With Pericardial WrapJohn K Forrest, Abeel A Mangi, Jeffrey J Popma, et al.
Frontiers in Cardiovascular Medicine|January 28, 2026
Intravascular brachytherapy vs. drug-coated balloons for in-stent restenosis in patients with diabetesGal Sella, Gera Gandelman, Alex Blatt, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 18, 2026
10-year experience with transcatheter aortic valve explants in a high-volume centerMarcell Szekely, Maria G Lopez-Trevino, Imre I Gecse, et al.
JAMA|October 27, 2020
Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical TrialMiguel Valderrábano, Leif E Peterson, Vijay Swarup, et al.
Translational Psychiatry|September 28, 2016
Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9AM S Alexander, M J Gasperini, P T Tsai, et al.
JAMA Network Open|October 27, 2022
Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical TrialDavid G Rizik, Vivek Rajagopal, Raj R Makkar, et al.
Cold Spring Harbor Molecular Case Studies|September 15, 2016
A novel de novo mutation in ATP1A3 and childhood-onset schizophreniaNiklas Smedemark-Margulies, Catherine A Brownstein, Sigella Vargas, et al.
Heart Rhythm|January 22, 2021
Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trialAdi Lador, Leif E Peterson, Vijay Swarup, et al.
American Heart Journal|April 1, 2009
Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registryEric M Crespo, Gustavo B F Oliveira, Emily F Honeycutt, et al.
European Heart Journal|April 3, 2009
Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromesDeepak L Bhatt, Eric D Peterson, Robert A Harrington, et al.
Pageof 169